Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 18 and 80 years, of any gender.
- People who have a single lung nodule and are already scheduled for a procedure to locate and mark that nodule.
- People whose chest CT scan shows the nodule measures 2 cm or smaller at its widest point.
- People with a general health and activity level that falls within a certain acceptable range, as measured by a standard medical scoring tool called the ECOG scale (scores 0–2, meaning able to carry out normal daily activities or only mildly limited).
- People who are willing to take part and have signed a consent form agreeing to join the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are not considered suitable for a type of minimally invasive chest surgery called video-assisted thoracoscopic surgery.
- People where the nodule is located very close to the diaphragm (the muscle beneath the lungs), specifically less than 3 cm from it.
- People who have a history of scar tissue forming inside the chest as a result of a previous open chest surgery or a past infection affecting the lining of the lungs.
- People whom the trial doctor has determined are not suitable for the standard pre-surgery nodule-marking procedure, whether performed through the chest wall or through the airways (confirm with trial site).
- People who are unlikely to be able to attend follow-up appointments or who may have difficulty following the trial's requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Haifeng Wang, Shanghai Pulmonary Hospital, Shanghai, China
Phone: +86 153 5656 1656
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Success rate of intraoperative localization of lung nodules
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.